I received by B.S. in Biomedical Sciences from Texas A&M University College Station in December 2017. While I was there, I worked on engineering DARPin inhibitors of C.diff toxin B. Upon graduation, I worked at Biodesix on their assay development team as well as at Lilly Biotechnology Center on their Protein Biosciences team. I entered Vanderbilt as part of the IGP program in 2018, and subsequently joined the Crowe Lab in 2019.
My research focuses on looking at the human immunome response to different infections, like Ebola and Flu using computational analysis along with experimental validation.